Screener
Adaptive Biotechnologies ADPT Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$39.94M-56.1% | -$20.02M+32.9% | -$13.58M+59.7% | $9.55M+130% | -$25.59M+44.7% | ||
| $3.27M-19.8% | $3.42M-20.7% | $3.77M-6.3% | $3.98M-4.5% | $4.08M-10.9% | ||
| $11.12M-16.8% | $11.93M-1.8% | $12.72M-0.9% | $13.26M-2.0% | $13.36M+3.1% | ||
| -$6.4M+48.5% | -$9.54M+66.5% | $0+100% | -$7.13M+73.7% | -$12.43M+28.2% | ||
| $1.18M+80.8% | $796K-36.8% | $636K+695% | $409K+18.9% | $655K-62.1% | ||
| -$43.48M-1,399% | $9.14M-64.2% | —— | $17.28M+227% | $3.35M-43.1% | ||
| $142.19M+8,732% | $7.5M+37.6% | $21.66M+16,954% | $1.68M+4,110% | $1.61M+5,267% | ||
| $92.31M+1,335% | $7.11M+180% | $15.46M— | $11.84M+154% | -$7.47M+34.4% | ||
| -$7.58M+42.0% | -$10.33M+65.3% | $0+100% | -$7.54M+72.5% | -$13.09M+31.2% |
FAQ
- How much cash does Adaptive Biotechnologies generate?
- Adaptive Biotechnologies (ADPT) generated -$23.1M in operating cash flow over the trailing twelve months.
- What is Adaptive Biotechnologies's free cash flow?
- After $3.0M of capital expenditures, Adaptive Biotechnologies's free cash flow was -$25.5M over the trailing twelve months, up 69.3% year over year.
- Where does Adaptive Biotechnologies's cash flow data come from?
- Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
